Hunan Jiutian Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or major omissions.
Special Reminder:
Due to the triggering of conditions for a downward adjustment of the conversion price of Jiutian Convertible Bonds 02 from May 14, 2026, to June 3, 2026, the Company's 18th meeting of the 4th Board of Directors reviewed and decided not to lower the conversion price this time. Furthermore, if the conditions are triggered again within the next six months (from June 4, 2026, to December 3, 2026), no downward adjustment proposal will be made. The conversion price will be recalculated on the first trading day after December 3, 2026, and if conditions are triggered again, the Board will review and decide whether to lower the conversion price according to relevant regulations.